JAK1/JAK3 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JAK1/JAK3 inhibitor, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome